{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:14:08Z","timestamp":1761311648722},"reference-count":46,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"DOI":"10.4269\/ajtmh.20-0190","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T07:01:05Z","timestamp":1592895665000},"page":"1258-1265","source":"Crossref","is-referenced-by-count":2,"title":["Post-Marketing Surveillance of Quality of Artemether Injection Marketed in Southwest Nigeria"],"prefix":"10.4269","volume":"103","author":[{"given":"Ibrahim A.","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebanjo J.","family":"Adegbola","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius O.","family":"Soyinka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyprian O.","family":"Onyeji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka, Nigeria"},{"name":"Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluseye O.","family":"Bolaji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"first-page":"30","volume-title":"Guidelines for the Treatment of Malaria","year":"2015","key":"b1"},{"key":"b2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12936-018-2254-0","article-title":"The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea","volume":"17","author":"Romay-Barja","year":"2018","journal-title":"Malar J"},{"key":"b3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12936-019-2995-4","article-title":"The economic burden of malaria on households and the health system in a high transmission district of Mozambique","volume":"18","author":"Alonso","year":"2019","journal-title":"Malar J"},{"key":"b4","doi-asserted-by":"crossref","first-page":"e1002815","DOI":"10.1371\/journal.pmed.1002815","article-title":"Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a longitudinal surveillance study","volume":"16","author":"Kenangalem","year":"2019","journal-title":"PLoS Med"},{"volume-title":"World Malaria Report","year":"2019","key":"b5"},{"key":"b6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1475-2875-11-S1-P122","article-title":"Nigerian malaria: the problems and the fight","volume":"11","author":"Okeke","year":"2012","journal-title":"Malar J"},{"key":"b7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3329\/seajph.v7i1.34672","article-title":"Major public health problems in Nigeria: a review","volume":"7","author":"Muhammad","year":"2017","journal-title":"South East Asia J Public Health"},{"volume-title":"President\u2019s Malaria Initiative Nigeria; Malaria Operational Plan FY 2019","year":"2019","key":"b8"},{"key":"b9","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/ph3072322","article-title":"Artesunate: the best drug in the treatment of severe and complicated malaria","volume":"3","author":"Li","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"b10","first-page":"CD010678","article-title":"Artemether for severe malaria","volume":"6","author":"Esu","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"b11","first-page":"29","article-title":"The treatment of complicated and severe malaria","volume":"75\u201376","author":"Pasvol","year":"2006","journal-title":"Br Med Bull"},{"key":"b12","doi-asserted-by":"crossref","first-page":"e1001938","DOI":"10.1371\/journal.pmed.1001938","article-title":"Intramuscular artesunate for severe malaria in African children: a multicenter randomized controlled trial","volume":"13","author":"Kremsner","year":"2016","journal-title":"PLoS Med"},{"key":"b13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4269\/ajtmh.2010.10-0158","article-title":"Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria","volume":"83","author":"Creek","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e2012026","DOI":"10.4084\/mjhid.2012.026","article-title":"Clinical aspects of uncomplicated and severe malaria","volume":"4","author":"Bartoloni","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"b15","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.47.12.3795-3798.2003","article-title":"Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria","volume":"47","author":"Silamut","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"b16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-3156.2008.02117.x","article-title":"Therapy of uncomplicated malaria in children: a review of treatment principles, essential drugs and current recommendations","volume":"13","author":"Deen","year":"2008","journal-title":"Trop Med Int Health"},{"key":"b17","doi-asserted-by":"crossref","first-page":"e84555","DOI":"10.1371\/journal.pone.0084555","article-title":"How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs","volume":"9","author":"Bruxvoort","year":"2014","journal-title":"PLoS One"},{"key":"b18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1475-2875-12-187","article-title":"Designing the next generation of medicines for malaria control and eradication","volume":"12","author":"Burrows","year":"2013","journal-title":"Malar J"},{"key":"b19","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000402","article-title":"A research agenda for malaria eradication: drugs","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"b20","doi-asserted-by":"crossref","first-page":"e181662","DOI":"10.1001\/jamanetworkopen.2018.1662","article-title":"Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis","volume":"1","author":"Ozawa","year":"2018","journal-title":"JAMA Network Open"},{"key":"b21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4269\/ajtmh.18-0334","article-title":"Modeling the economic impact of substandard and falsified antimalarials in the Democratic Republic of the Congo","volume":"100","author":"Ozawa","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"b22","doi-asserted-by":"crossref","first-page":"e0217910","DOI":"10.1371\/journal.pone.0217910","article-title":"The economic impact of substandard and falsified antimalarial medications in Nigeria","volume":"14","author":"Beargie","year":"2019","journal-title":"PLoS One"},{"key":"b23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fpubh.2019.00342","article-title":"Unintended consequences and hidden obstacles in medicine access in sub-Saharan Africa","volume":"7","author":"Barton","year":"2019","journal-title":"Front Public Health"},{"key":"b24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4269\/ajtmh.18-0981","article-title":"Falsified and substandard drugs: stopping the pandemic","volume":"100","author":"Nayyar","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"b25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.14-0535","article-title":"Monitoring the quality of medicines: results from Africa, Asia, and South America","volume":"92","author":"Hajjou","year":"2015","journal-title":"Am J Trop Med Hyg"},{"volume-title":"Landscape of Antimalarial Medicines in Nigeria","year":"2016","key":"b26"},{"volume-title":"Global Surveillance and Monitoring System for Substandard and Falsified Medical Products","year":"2017","key":"b27"},{"key":"b28","doi-asserted-by":"crossref","first-page":"e1000052","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"b29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2875-8-22","article-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","volume":"8","author":"Onwujekwe","year":"2009","journal-title":"Malar J"},{"key":"b30","doi-asserted-by":"crossref","first-page":"e0125577","DOI":"10.1371\/journal.pone.0125577","article-title":"Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria","volume":"10","author":"Kaur","year":"2015","journal-title":"PLoS One"},{"key":"b31","first-page":"274","article-title":"Assessment of quality of commercially available artemether\u2013lumefantrine tablets in Rivers state, Nigeria","volume":"6","author":"Mgbahurike","year":"2017","journal-title":"World J Pharm Res"},{"key":"b32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/trstmh\/trx019","article-title":"Quality of artemisinin-based antimalarial drugs marketed in Nigeria","volume":"111","author":"Izevbekhai","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b33","first-page":"81","article-title":"Quality assessment of twenty brands of sulfadoxine-pyrimethamine tablets marketed in Mainland","volume":"43","author":"Adeyemi","year":"2018","journal-title":"J Chem Soc Nigeria"},{"key":"b34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/njbcs.njbcs_4_17","article-title":"Fake drugs: a survey of healthcare providers in Lagos state, Nigeria","volume":"14","author":"Joda","year":"2017","journal-title":"Niger J Basic Clin Sci"},{"year":"2019","author":"Nations","key":"b35"},{"key":"b36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5923\/j.re.20120202.06","article-title":"Constraints to forest policy implementation in the southwest Nigeria: causes, consequences and cure","volume":"2","author":"Faleyimu","year":"2012","journal-title":"Resour Environ"},{"volume-title":"Biostatistics: A Foundation for Analysis in the Health Sciences","year":"1999","author":"Daniel","key":"b37"},{"article-title":"Artemether injection monograph","volume-title":"The International Pharmacopoeia","year":"2019","key":"b38"},{"volume-title":"Bioanalytical Method Validation Guidance for Industry","year":"2018","key":"b39"},{"key":"b40","first-page":"89","article-title":"Dihydroartemisinin photoirradiation: reduced antiplasmodic activity and toxicological implications","volume":"19","author":"Adegbolagun","year":"2016","journal-title":"Afr J Biomed Res"},{"volume-title":"Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products; Guidance for Industry","year":"2015","key":"b41"},{"key":"b42","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4269\/ajtmh.18-0845","article-title":"Artemisinin resistance outside of Southeast Asia","volume":"99","author":"Rosenthal","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/parasite\/2018021","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination","volume":"25","author":"Ouji","year":"2018","journal-title":"Parasite"},{"key":"b44","first-page":"806416","article-title":"Evaluation of the quality of artemisinin-based antimalarial medicines distributed in Ghana and Togo","volume":"2014","author":"Osei-Safo","year":"2014","journal-title":"Malar Res Treat"},{"key":"b45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0972-9062.213452","article-title":"Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana","volume":"49","author":"El-Duah","year":"2012","journal-title":"J Vector Borne Dis"},{"key":"b46","doi-asserted-by":"crossref","first-page":"8602619","DOI":"10.1155\/2016\/8602619","article-title":"Quality assessment of artemether-lumefantrine samples and artemether injections sold in the cape coast metropolis","volume":"2016","author":"Prah","year":"2016","journal-title":"J Trop Med"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:16:48Z","timestamp":1723094208000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0190","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"type":"print","value":"0002-9637"},{"type":"electronic","value":"1476-1645"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}